Subthreshold Micropulse Laser Treatment of Acute Central Serous Chorioretinopathy
Sponsor
Minia University (Other)
Overall Status
Completed
CT.gov ID
NCT05447117
Collaborator
(none)
42
1
32.5
1.3
Study Details
Study Description
Brief Summary
To evaluate the efficacy and safety of 532 nm green subthreshold micropulse laser (GSML) as a treatment for acute central serous chorioretinopathy (CSCR).
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
N/A |
Detailed Description
This prospective study included 42 eyes of 42 patients with acute CSCR treated with IRIDEX™ IQ 532 nm GSML. The study was conducted at Minia University Hospital and Genaidy Ophthalmology Center, Minia, Egypt between October 2019 and May 2022. All patients were subjected to a complete ophthalmological examination, fluorescein angiography (FA) and optical coherence tomography (OCT) at baseline and each follow-up visit 1, 3 and 18 months after laser treatment
Study Design
Study Type:
Interventional
Actual Enrollment
:
42 participants
Allocation:
Non-Randomized
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Subthreshold Micropulse 532 nm Green Laser Treatment of Acute Central Serous Chorioretinopathy: 18-month Results
Actual Study Start Date
:
Oct 15, 2019
Actual Primary Completion Date
:
May 30, 2022
Actual Study Completion Date
:
Jun 30, 2022
Outcome Measures
Primary Outcome Measures
- change in visual acuity [18 months]
resolution of subretinal fluid
Eligibility Criteria
Criteria
Ages Eligible for Study:
N/A
and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
- acute CSCR
Exclusion Criteria:
- chronic CSCR Previously treated case of Acute CSCR
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Minia University Hospital | Minya | Minia | Egypt | 61111 |
Sponsors and Collaborators
- Minia University
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Hosny Ahmed Zein,
DR,
Minia University
ClinicalTrials.gov Identifier:
NCT05447117
Other Study ID Numbers:
- CSCR2019
First Posted:
Jul 7, 2022
Last Update Posted:
Jul 7, 2022
Last Verified:
Jul 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms: